
Edwards Lifesciences – the leading global structural heart innovation ...
Explore the life and culture of working at Edwards Lifesciences Join our passionate and innovative teams around the world Discover a career where your work transforms patient lives Kickstart your …
Contact Us | Edwards Lifesciences
Careers at Edwards Discover an exciting career at a company dedicated to improving patient lives.
Who we are - Edwards Lifesciences
Who we are Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives.
Our leaders | Edwards Lifesciences
Building from Edwards’ foundation rooted in the company’s Credo, the patient-focused culture and the unique innovation strategy, Zovighian and the global Edwards employees are united and inspired to …
Careers | Edwards Lifesciences
Our locations With more than 16,000 employees across the globe, we celebrate our inclusive culture and embrace the diverse perspectives and experiences of our Edwards team. No matter your …
Locations - Edwards Lifesciences
Headquartered in Irvine, California, our teams work together to create a sense of community and are focused on supporting what is best for Edwards and the patient.
Edwards Lifesciences Corp - Overview
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships …
Israel - Edwards Lifesciences
The Edwards Israel Innovation Center (EIIC) focuses on developing early-stage cardiovascular technologies. Our passion, ingenuity, collaboration, and new ways of thinking enable us to develop …
Hemodynamic Monitoring | Edwards Lifesciences
Advanced hemodynamic monitoring Solutions designed for individualized patient management Edwards Lifesciences Critical Care product group is now part of BD (Becton, Dickinson and Company). …
Edwards Comments on JenaValve Acquisition
Jan 9, 2026 · As a result, Edwards will not acquire JenaValve. Edwards disagrees with the decision and believes that the acquisition would have been in the best interest of a large, growing and …